Tapewire

NYSE · USD

EW

Edwards Lifesciences Corp

Export transactions ↓
Tapewire entity
3026
SEC CIK
0001099800
Parsed reports
947

Last 12 months

Inside the activity.

0 purchase rows · 54 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202503
Dec 2025010
Jan 202603
Feb 202603
Mar 202604
Apr 202605
May 2026012
Jun 202602
Jul 202604
Aug 202606
Sep 202601
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 15, 2020 Filed Jun 16, 2020 20:17 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 37,312 $68.81 $2,567,438.72
Disclosure

SEC source: 0001225208-20-009020 · doc4.xml · nonDerivative · entry 5

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 241,220.46

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020.

F5 · price: This transaction was executed in multiple trades at prices ranging from $68.35 to $69.33. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 20:17 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 21,938 $67.65 $1,484,105.70
Disclosure

SEC source: 0001225208-20-009020 · doc4.xml · nonDerivative · entry 4

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 278,532.46

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020.

F4 · price: This transaction was executed in multiple trades at prices ranging from $67.33 to $68.315. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 20:17 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 6,200 $66.91 $414,842.00
Disclosure

SEC source: 0001225208-20-009020 · doc4.xml · nonDerivative · entry 3

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,470.46

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020.

F3 · price: This transaction was executed in multiple trades at prices ranging from $66.34 to $67.32. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 20:17 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
SaleCommon Stock 3,100 $69.00 $213,900.00
Disclosure

SEC source: 0001225208-20-009020 · doc4.xml · nonDerivative · entry 2

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 306,670.46

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $69.335 to $69.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 15, 2020 Filed Jun 16, 2020 20:17 UTC
MUSSALLEM MICHAEL ADirector · Chairman & CEO
Exercise / conversionCommon Stock 98,550 $13.98 $1,377,729.00
Disclosure

SEC source: 0001225208-20-009020 · doc4.xml · nonDerivative · entry 1

MUSSALLEM MICHAEL A · CIK 0001204551 · Director · Chairman & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 309,770.46

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 3, 2020.

Read SEC document
June 12, 2020 Filed Jun 12, 2020 21:11 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 13,074 $0.00 Strike: $13.98 $0.00
Disclosure

SEC source: 0001225208-20-008937 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,752

Underlying: Common Stock · 13,074 shares

Expires 2021-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2020.

Read SEC document
June 12, 2020 Filed Jun 12, 2020 21:11 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 13,074 $69.86 $913,313.03
Disclosure

SEC source: 0001225208-20-008937 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,751.5507

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $69.51 to $70.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 12, 2020 Filed Jun 12, 2020 21:11 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 13,074 $13.98 $182,774.52
Disclosure

SEC source: 0001225208-20-008937 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,825.5507

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2020.

Read SEC document
June 11, 2020 Filed Jun 11, 2020 22:57 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 11,649 $0.00 Strike: $13.98 $0.00
Disclosure

SEC source: 0001225208-20-008854 · doc4.xml · derivative · entry 5

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 93,204

Underlying: Common Stock · 11,649 shares

Expires 2021-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
June 11, 2020 Filed Jun 11, 2020 22:57 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 8,362 $71.25 $595,792.50
Disclosure

SEC source: 0001225208-20-008854 · doc4.xml · nonDerivative · entry 4

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 94,220.7768

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

F3 · price: This transaction was executed in multiple trades at prices ranging from $70.88 to $71.86. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 11, 2020 Filed Jun 11, 2020 22:57 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 3,287 $72.42 $238,053.41
Disclosure

SEC source: 0001225208-20-008854 · doc4.xml · nonDerivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,582.7768

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

F2 · price: This transaction was executed in multiple trades at prices ranging from $71.90 to $72.59. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
June 11, 2020 Filed Jun 11, 2020 22:57 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 84 $72.59 $6,097.56
Disclosure

SEC source: 0001225208-20-008854 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,869.7768

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
June 11, 2020 Filed Jun 11, 2020 22:57 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 11,649 $13.98 $162,853.02
Disclosure

SEC source: 0001225208-20-008854 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,953.7768

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
June 11, 2020 Filed Jun 11, 2020 22:54 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 2,249 $72.59 $163,254.91
Disclosure

SEC source: 0001225208-20-008853 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,563.6694

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
June 01, 2020 Filed Jun 1, 2020 23:56 UTC
Wood Larry LCVP, TAVR
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 10,698 $0.00 Strike: $21.76 $0.00
Disclosure

SEC source: 0001225208-20-008398 · doc4.xml · derivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,212

Underlying: Common Stock · 10,698 shares

Expires 2022-05-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2019.

Read SEC document
June 01, 2020 Filed Jun 1, 2020 23:56 UTC
Wood Larry LCVP, TAVR
SaleCommon Stock 10,698 $75.30 $805,559.40
Disclosure

SEC source: 0001225208-20-008398 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 363,398.7141

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2019.

Read SEC document
June 01, 2020 Filed Jun 1, 2020 23:56 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 10,698 $21.76 $232,788.48
Disclosure

SEC source: 0001225208-20-008398 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 374,096.7141

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 12, 2019.

Read SEC document
May 29, 2020 Filed Jun 22, 2020 21:16 UTC
Ullem Scott B.CVP, Chief Financial Officer
GiftCommon Stock 14,487 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009143 · doc4.xml · nonDerivative · entry 5

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 229,251

F1 · shares: On May 29, 2020, the Insider transferred into his trust 14,487 common shares, which reflects the 3-for-1 stock split that occurred on the same day.

Read SEC document
May 29, 2020 Filed Jun 22, 2020 21:16 UTC
Ullem Scott B.CVP, Chief Financial Officer
GiftCommon Stock 14,487 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-009143 · doc4.xml · nonDerivative · entry 1

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,114

F1 · shares: On May 29, 2020, the Insider transferred into his trust 14,487 common shares, which reflects the 3-for-1 stock split that occurred on the same day.

Read SEC document
May 18, 2020 Filed May 18, 2020 21:42 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 1,717 $216.68 $372,039.56
Disclosure

SEC source: 0001225208-20-007962 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,434.9256

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 15, 2020 Filed May 15, 2020 20:52 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 4,358 $0.00 Strike: $41.94 $0.00
Disclosure

SEC source: 0001225208-20-007835 · doc4.xml · derivative · entry 6

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,942

Underlying: Common Stock · 4,358 shares

Expires 2021-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2020.

Read SEC document
May 15, 2020 Filed May 15, 2020 20:52 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
SaleCommon Stock 4,358 $215.16 $937,667.28
Disclosure

SEC source: 0001225208-20-007835 · doc4.xml · nonDerivative · entry 2

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,250.5169

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2020.

Read SEC document
May 15, 2020 Filed May 15, 2020 20:52 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Exercise / conversionCommon Stock 4,358 $41.94 $182,774.52
Disclosure

SEC source: 0001225208-20-007835 · doc4.xml · nonDerivative · entry 1

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,608.5169

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 30, 2020.

Read SEC document
May 14, 2020 Filed May 14, 2020 20:12 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 1,116 $212.69 $237,362.04
Disclosure

SEC source: 0001225208-20-007661 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,270.8898

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 13, 2020 Filed May 13, 2020 22:28 UTC
Szyman Catherine M.CVP, Critical Care
SaleCommon Stock 750 $216.93 $162,697.50
Disclosure

SEC source: 0001225208-20-007628 · doc4.xml · nonDerivative · entry 5

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,386.8898

F2 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 12, 2020 Filed May 13, 2020 22:28 UTC
Szyman Catherine M.CVP, Critical Care
Tax withholdingCommon Stock 682 $225.05 $153,484.10
Disclosure

SEC source: 0001225208-20-007628 · doc4.xml · nonDerivative · entry 4

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,136.8898

Read SEC document
May 12, 2020 Filed May 13, 2020 20:20 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 707 $225.05 $159,110.35
Disclosure

SEC source: 0001225208-20-007587 · doc4.xml · nonDerivative · entry 4

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,132.9047

Read SEC document
May 12, 2020 Filed May 13, 2020 20:19 UTC
WANG HUIMINCVP, Japan & Intercontinental
Tax withholdingCommon Stock 358 $225.05 $80,567.90
Disclosure

SEC source: 0001225208-20-007585 · doc4.xml · nonDerivative · entry 4

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,151.9256

Read SEC document
May 12, 2020 Filed May 13, 2020 20:17 UTC
Ullem Scott B.CVP, Chief Financial Officer
Tax withholdingCommon Stock 726 $225.05 $163,386.30
Disclosure

SEC source: 0001225208-20-007578 · doc4.xml · nonDerivative · entry 4

Ullem Scott B. · CIK 0001446989 · CVP, Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,867

Read SEC document
May 12, 2020 Filed May 13, 2020 20:15 UTC
SELLERS ROBERT W.A.VP, Corporate Controller
Tax withholdingCommon Stock 88 $225.05 $19,804.40
Disclosure

SEC source: 0001225208-20-007575 · doc4.xml · nonDerivative · entry 2

SELLERS ROBERT W.A. · CIK 0001600739 · VP, Corporate Controller

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,941.7761

Read SEC document
May 12, 2020 Filed May 13, 2020 20:11 UTC
Lemercier Jean-Luc MCVP, EMEA, Canada, Latin Amer
Tax withholdingCommon Stock 25 $225.05 $5,626.25
Disclosure

SEC source: 0001225208-20-007573 · doc4.xml · nonDerivative · entry 4

Lemercier Jean-Luc M · CIK 0001710625 · CVP, EMEA, Canada, Latin Amer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,385.0477

Read SEC document
May 12, 2020 Filed May 13, 2020 20:09 UTC
BOBO DONALD E JRCVP,Strategy/Corp Development
Tax withholdingCommon Stock 709 $225.05 $159,560.45
Disclosure

SEC source: 0001225208-20-007572 · doc4.xml · nonDerivative · entry 4

BOBO DONALD E JR · CIK 0001196661 · CVP,Strategy/Corp Development

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,250.5169

Read SEC document
May 11, 2020 Filed May 11, 2020 21:40 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionEmployee Stock Option (Right to Acquire) · Derivative 3,883 $0.00 Strike: $41.94 $0.00
Disclosure

SEC source: 0001225208-20-007420 · doc4.xml · derivative · entry 7

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,951

Underlying: Common Stock · 3,883 shares

Expires 2021-05-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 11, 2020 Filed May 11, 2020 21:40 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 3,820 $219.03 $836,694.60
Disclosure

SEC source: 0001225208-20-007420 · doc4.xml · nonDerivative · entry 6

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,210.9256

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 11, 2020 Filed May 11, 2020 21:40 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 44 $219.07 $9,639.08
Disclosure

SEC source: 0001225208-20-007420 · doc4.xml · nonDerivative · entry 5

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,030.9256

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 11, 2020 Filed May 11, 2020 21:40 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 10 $218.66 $2,186.60
Disclosure

SEC source: 0001225208-20-007420 · doc4.xml · nonDerivative · entry 4

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,074.9256

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 11, 2020 Filed May 11, 2020 21:40 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 5 $219.96 $1,099.80
Disclosure

SEC source: 0001225208-20-007420 · doc4.xml · nonDerivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,084.9256

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 11, 2020 Filed May 11, 2020 21:40 UTC
WANG HUIMINCVP, Japan & Intercontinental
SaleCommon Stock 4 $218.75 $875.02
Disclosure

SEC source: 0001225208-20-007420 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,089.9256

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 11, 2020 Filed May 11, 2020 21:40 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionCommon Stock 3,883 $41.94 $162,853.02
Disclosure

SEC source: 0001225208-20-007420 · doc4.xml · nonDerivative · entry 1

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,093.9256

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2020.

Read SEC document
May 11, 2020 Filed May 13, 2020 22:28 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionPerformance Rights · Derivative 5,950 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-007628 · doc4.xml · derivative · entry 6

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,950 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.exercise_date: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.expiration_date: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.underlying_shares: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

Read SEC document
May 11, 2020 Filed May 13, 2020 22:28 UTC
Szyman Catherine M.CVP, Critical Care
Tax withholdingCommon Stock 2,951 $217.84 $642,845.84
Disclosure

SEC source: 0001225208-20-007628 · doc4.xml · nonDerivative · entry 3

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,818.8898

Read SEC document
May 11, 2020 Filed May 13, 2020 22:28 UTC
Szyman Catherine M.CVP, Critical Care
Tax withholdingCommon Stock 548 $217.84 $119,376.32
Disclosure

SEC source: 0001225208-20-007628 · doc4.xml · nonDerivative · entry 2

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,769.8898

Read SEC document
May 11, 2020 Filed May 13, 2020 22:28 UTC
Szyman Catherine M.CVP, Critical Care
Exercise / conversionCommon Stock 5,950 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-007628 · doc4.xml · nonDerivative · entry 1

Szyman Catherine M. · CIK 0001438538 · CVP, Critical Care

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,317.8898

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · price: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

Read SEC document
May 11, 2020 Filed May 13, 2020 20:20 UTC
Wood Larry LCVP, TAVR
Exercise / conversionPerformance Rights · Derivative 6,343 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-007587 · doc4.xml · derivative · entry 6

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,343 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.exercise_date: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.expiration_date: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.underlying_shares: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

Read SEC document
May 11, 2020 Filed May 13, 2020 20:20 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 3,145 $217.84 $685,106.80
Disclosure

SEC source: 0001225208-20-007587 · doc4.xml · nonDerivative · entry 3

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,839.9047

Read SEC document
May 11, 2020 Filed May 13, 2020 20:20 UTC
Wood Larry LCVP, TAVR
Tax withholdingCommon Stock 719 $217.84 $156,626.96
Disclosure

SEC source: 0001225208-20-007587 · doc4.xml · nonDerivative · entry 2

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 124,984.9047

Read SEC document
May 11, 2020 Filed May 13, 2020 20:20 UTC
Wood Larry LCVP, TAVR
Exercise / conversionCommon Stock 6,343 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-007587 · doc4.xml · nonDerivative · entry 1

Wood Larry L · CIK 0001440660 · CVP, TAVR

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 125,703.9047

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · price: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

Read SEC document
May 11, 2020 Filed May 13, 2020 20:19 UTC
WANG HUIMINCVP, Japan & Intercontinental
Exercise / conversionPerformance Rights · Derivative 3,281 $0.00 $0.00
Disclosure

SEC source: 0001225208-20-007585 · doc4.xml · derivative · entry 5

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,281 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.exercise_date: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.expiration_date: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

F1 · derivative.underlying_shares: On May 11, 2017, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2020, the Compensation Committee of the Board of Directors determined that 175% of the target shares would vest as of May 11, 2020, and the actual number of shares vested are reflected on this Form.

Read SEC document
May 11, 2020 Filed May 13, 2020 20:19 UTC
WANG HUIMINCVP, Japan & Intercontinental
Tax withholdingCommon Stock 1,627 $217.84 $354,425.68
Disclosure

SEC source: 0001225208-20-007585 · doc4.xml · nonDerivative · entry 3

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,329.9256

Read SEC document
May 11, 2020 Filed May 13, 2020 20:19 UTC
WANG HUIMINCVP, Japan & Intercontinental
Tax withholdingCommon Stock 355 $217.84 $77,333.20
Disclosure

SEC source: 0001225208-20-007585 · doc4.xml · nonDerivative · entry 2

WANG HUIMIN · CIK 0001204553 · CVP, Japan & Intercontinental

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,956.9256

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.